TB4 Full Sequence (Thymosin Beta-4) | 10mg

TB4 Full Sequence (Thymosin Beta-4) | 10mg

Not all Thymosin Beta-4 products are equal. TB4 Full Sequence is the complete, naturally occurring 43 amino acid peptide — the same molecule your body produces and releases in response to injury and cellular stress. Where TB-500 is a shorter synthetic fragment derived from TB4’s active region, the full sequence interacts with a significantly broader range of biological pathways, offering a more comprehensive and biologically complete profile for research applications.

What Research Suggests TB4 Full Sequence May Support:

Tissue Repair & Regeneration — As the complete, biologically active form, TB4 Full Sequence supports the full cascade of repair signalling — mobilising stem and progenitor cells, promoting their migration to sites of injury, and driving organised tissue regeneration across muscle, tendon, ligament, and connective tissue.

Angiogenesis & Vascular Support — Research has demonstrated TB4’s role in promoting new blood vessel formation through upregulation of VEGF signalling and endothelial cell sprouting — supporting oxygen and nutrient delivery to damaged tissue throughout the repair process.

Cardiac Repair & Protection — One of the most compelling areas of TB4 research involves its role in cardiac regeneration. Studies have shown it activates epicardial progenitor cells, promotes coronary vessel formation, and can reactivate embryonic repair processes in adult heart tissue — pointing to applications well beyond musculoskeletal recovery.

Anti-Inflammatory & Anti-Fibrotic Effects — Research demonstrates TB4 reduces pro-inflammatory cytokines, suppresses NF-κB activation, and decreases the number of myofibroblasts at the wound site — resulting in faster, cleaner healing with significantly reduced scarring and fibrosis compared to controls.

Neuroprotection & CNS Recovery — Studies point to meaningful neuroprotective activity in models of traumatic brain injury, spinal cord compression, and stroke, with TB4 supporting neuronal survival, reducing neuroinflammation, and promoting recovery of function in preclinical models.

Ocular Health — Human clinical trials have demonstrated TB4 improves conditions including dry eye and neurotrophic keratopathy, with therapeutic effects observed to persist well beyond the end of treatment — making it one of the few peptides with meaningful human clinical data in this area.

Broader Biological Activity Than TB-500 — As the full sequence, TB4 interacts with the complete actin-binding complex and multiple additional domain-dependent pathways that shorter fragments cannot replicate — making it the preferred choice for research requiring the most comprehensive biological activity profile.

For research purposes only. Not approved for human therapeutic use. Always consult a qualified healthcare professional.